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RTS,S was the first vaccine for Malaria approved for use by the European Medicines Agency 
and it is set to be administered to 360,000 children in Malawi, Ghana, and Kenya as part of a 
pilot implementation program in fall 2018.  The efficacy of RTS,S was variable, possibly due to 
differences in transmission intensity, between the 11 sites and 7 countries participating in the 
2009-2014 phase III trials. However, a within-site analysis examining environmental factors 
related to transmission intensity has yet to be conducted.  
Methods 
We used data from the phase III trial of RTS,S, which enrolled 1,578 infants (6-12 weeks) and 
children (5-17 months) living in the Lilongwe District in Central Malawi and followed them for 
up to 4 years. A global positioning system survey and an ecological questionnaire were used to 
collect household locations and characteristics in order to investigate whether spatial location or 
household ecological factors were associated with the efficacy of RTS,S. We used negative 
binomial regression models to assess the effect of the vaccine on number of malaria episodes. 
Results 
Using data from 1189 (75.3%) of the phase III participants, we found that the location-specific 
malaria incidence varied over the study region from .072 to 2.11 estimated episodes per year. We 
found no evidence supporting the hypothesis that the efficacy of the RTS,S vaccine varied over 
the Lilongwe study region. We also found that malaria incidence was associated with grass roofs, 
certain window types, proximity to a waterway and low population density. However, we found 
no evidence supporting the hypothesis that these ecological variables impacted the efficacy of 
RTS,S. 
Discussion 
Our results suggest that transmission intensity did not play a role in the intra-site efficacy of 
RTS,S in Lilongwe, Malawi during the phase III trial.  
INTRODUCTION 
Background 
Malaria draws its name from the miasma paradigm of the Middle Ages: ‘mal aria’ literally 
translates to ‘bad air.’ Of course, now we know that Malaria is a vector-borne eukaryotic parasite 
transmitted by the Anopholes mosquito. Being vector-borne, the parasite is tethered to regions 
which can support the mosquito. In 2016, malaria caused an estimated 216 million clinical 
episodes and 445,000 deaths, with an estimated 91% of these deaths occurring in Africa [1]. Not 
only does Malaria impact health, it impacts the economic development of endemic countries as 
well. According to renowned Columbia Economist Jeffrey Sachs, a 10% reduction in malaria 
from 1965 to 1990 corresponded to a 0.3% increase in annual economic growth, taking into 
account initial poverty, economic policy, tropical location and other factors [2]. 
Due to control efforts, the number of deaths due to malaria has been cut in half since the turn of 
the century [3]. In addition to current control efforts, public health practitioners now have a 
working vaccine; RTS,S, which is currently the only vaccine against malaria which has been 
approved for use by the European Medicines Agency [4]. RTS,S is given in three doses, 
administered in one month intervals with an additional booster dose recommended to maximize 
efficacy. RTS,S is set to be administered to 360,000 children in Malawi, Ghana, and Kenya as 
part of a pilot implementation program in the fall of 2018. Children are primarily being targeted 
for vaccination as malaria tends to be more severe in children under 5, who account for around 
70% of malaria deaths in Africa and worldwide [5].  
RTS,S was shown to be 36.3% effective , in terms of relative risk reduction, against clinical 
malaria over a 24 month period in children aged 5-17 months receiving the 4 dose regimen 
during a phase III trial, which was conducted in 11 sites across 7 countries from 2009 to 2014 
[6]. Despite its lower-than-expected efficacy, this vaccine could have an important public health 
impact when used in conjunction with other malaria prevention methods. RTS,S is a cost-
effective control measure. Using mathematical modeling, one group estimated that a four dose 
schedule would avert one clinical case of malaria per every $25 spent [7]. 
Interestingly, the efficacy of the vaccine was not uniform across all trial sites, ranging from 22% 
in Manhica, Mozambique to 74.6% in Kilifi, Kenya [6]. This between-site variation of vaccine 
efficacy suggests that there may be environmental factors influencing trial results. Additionally, 
it has been noted that the vaccine tends to have a higher efficacy in higher transmission intensity 
areas [7]. Before wide-scale implementation, it will be important to understand what conditions 
will maximize the impact of administration of the vaccine on the per-participant, intra-site level.  
Lilongwe is the capital city of Malawi and was a site in the 2009-2014 phase III trial of RTS,S. It 
is a peri-urban city, meaning that it is an area where urban and rural qualities mix to different 
degrees across the study site. This variation of environment makes Lilongwe an ideal candidate 
for a within-site examination of the variations of vaccine efficacy due to changes in transmission 
intensity. We used spatial location and ecological variables as proxies for transmission intensity 
and examined whether there was variation of vaccine efficacy within the Lilongwe site. This 
study asked the following two questions: (1) Was there significant spatial variation in the total 
number of malaria episodes seen in the phase III trial in Lilongwe, Malawi? (2) Did the efficacy 
of the RTS,S malaria vaccine depend upon the location of the subject or certain ecological 
factors related to malaria incidence? We hypothesized that there would be spatial variation in 
malaria episodes and in vaccine efficacy and that certain ecological factors would modify the 
effect of the treatment. 
 
METHODS 
The study population included infants aged 6-12 weeks and children aged 5-17 months enrolled 
in the 2009-2014 phase III trial of RTS,S in Lilongwe, Malawi (n = 1578). 
The phase III trial was double blind, observer blind, and individually randomized-controlled. 
Lilongwe was one site out of 11 in 7 countries. Participants were split based on age group, infant 
(6-12 weeks) or child (5-17 months), and then randomized into control (C3C), vaccine (R3C), 
and vaccine + booster (R3R) groups. All participants received 3 doses of the RTS,S vaccine or a 
control vaccine on months 0, 1, and 2 of follow up. They then received a booster or control 
vaccine on month 22 of follow up, 20 months after receiving the third dose of the base vaccine. 
Participants were tested for malaria every 6 months during follow up. Additionally, participants 
were able to come in for testing whenever they desired. If the participant was found to have 
malaria, they received treatment [6]. 
The outcome, an episode of clinical malaria, was defined as illness accompanied by an axillary 
temperature of at least 37.5°C and P.  falciparum asexual parasitaemia (>5000 parasites per 
mm³), as seen by microscopy [6]. 
The key exposures of interest in this analysis were spatial location and ecological factors. The 
aspects of ecology taken into account were roof type, window type, population density, and 
distance to nearest river or stream.  
An ecological survey was administered in months 6, 12, 18, and 24 of a participant’s enrollment 
in the trial. Point locations of the participant’s household and characteristics of the participant’s 
environment were recorded. Roof type (grass or metal), window type (glass, screen, open, 
plastic/paper/carton, planks or no window) were taken from this survey. Some observations had 
multiple window types recorded. In these instances, we used the window type that evinced the 
highest risk of malaria transmission. The combinations present, in order of frequency, were: 
glass and open (20), glass and screen (4), glass and plastic/paper/carton (3), glass and planks (3), 
screen and open (3), open and planks (3), open and no window (2), open and plastic/paper/carton 
(1), screen and plastic/paper/carton (1). Since we could distinguish which window type between 
each pair was worse, we removed the better window type to essentially create a ‘worst window 
type’ variable. 
A raster of population density values from 2010 that were estimated over 100m by 100m (1 
hectare) squares was obtained from WorldPop. Underlying raster values were extracted to 
subject household locations using QGIS. A waterway layer was extracted from OpenStreetMap 
using Overpass Turbo and the criteria waterway=stream or waterway=river. In order to calculate 
distance to nearest river values, point locations and a waterway layer were projected to WGS84 
UTM36S in R and distances were calculated using rgeos::gDistance. 
Potential Confounders 
Age group was included since participant location and susceptibility to malaria were likely 
influenced by age. 
Statistical Analysis 
First, we calculated summary statistics in order to describe the sample. Next we determined if 
malaria incidence varied geographically over our study area. A negative binomial regression 
model was used in order to model the log of expected malaria count, ln⁡(𝐸[𝑌]), over the trial 
period. An offset representing follow-up time, ln(𝑡𝑖𝑚𝑒𝑖), was used. This is equivalent to 
modeling incidence, ln⁡(𝐸[𝑌/𝑡𝑖𝑚𝑒𝑖]), with no offset. A spatial smoother, 𝑆, was included and is 
analogous to a random intercept depending on geographic location.  
1) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝑆𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
2) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 + 𝑆𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
Next, we determined if vaccine efficacy was associated with geographic location. We used a 
similar regression model, but we added in treatment effect as well as an interaction with 
treatment group and the spatial smoother. 
3) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝑆𝑖 + ⁡⁡𝛽3𝑡𝑟𝑡𝑖 ∗ 𝑆𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
Next, we determined if our ecological variables were related to malaria incidence. This model 
included each of our ecological variables, a spatial random effect, and an interaction between age 
group and treatment group which was found to be significant by the RTS,S Clinical Trials 
Partnership [6]. 
4) ln(𝐸[𝑌𝑖]) =
⁡𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝛽3𝑎𝑔𝑒𝑖 ∗ 𝑡𝑟𝑡𝑖 + ⁡𝛽4𝑟𝑜𝑜𝑓𝑖 + ⁡𝛽5𝑤𝑖𝑛𝑑𝑖⁡+⁡𝛽6𝑑𝑖𝑠𝑡𝑖+⁡𝛽7𝑑𝑒𝑛𝑠𝑖 +
𝑆𝑖 +⁡ln(𝑡𝑖𝑚𝑒𝑖) 
Next, we determined if certain ecological variables were associated with vaccine efficacy. Each 
ecological variable was modeled separately – roof type, window type, distance to nearest river or 
stream and population density. In this group of models, the significance of the interaction term 
between treatment group and the ecological variable in question and spatial pattern of the 
residuals was investigated. 
5) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝛽3𝑟𝑜𝑜𝑓𝑖⁡+⁡𝛽4𝑡𝑟𝑡𝑖 ∗ 𝑟𝑜𝑜𝑓𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
6) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝛽3𝑤𝑖𝑛𝑑𝑖⁡+⁡𝛽4𝑡𝑟𝑡𝑖 ∗ 𝑤𝑖𝑛𝑑𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
7) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝛽3𝑑𝑖𝑠𝑡𝑖⁡+⁡𝛽4𝑡𝑟𝑡𝑖 ∗ 𝑑𝑖𝑠𝑡𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
8) ln⁡(𝐸[𝑌𝑖]) = 𝛽0 + 𝛽1𝑎𝑔𝑒𝑖 +⁡𝛽2𝑡𝑟𝑡𝑖⁡+⁡𝛽3𝑑𝑒𝑛𝑠𝑖 + ⁡𝛽4𝑡𝑟𝑡𝑖 ∗ 𝑑𝑒𝑛𝑠𝑖 + ln(𝑡𝑖𝑚𝑒𝑖) 
The parameters of each model described here were not estimated using traditional multivariable 
regression. Due to the complexity of the spatial term, the parameters were estimated using a thin 
plate regression spline, implemented in the ‘mgcv’ package in R. A spline is a method of 
modeling outcomes as non-linear functions of location. It does this by minimizing the residuals 
of the fitted model with an additional penalty on the squared second derivative of the spatial 
surface. This effectively reduces the ‘wigglyness’ of the fitted model, reducing the impact that 
random noise might have on the model fit. For the fitting of a spatial random effect surface, this 
is helpful in attempting to recover the true underlying spatial process. The equation that the thin 







Participants were enrolled into either the control group (C3C), the vaccine group (R3C), or the 
vaccine and booster group (R3R). Thirty-seven participants were immediately lost to follow-up 
upon enrollment and one participant did not have geographic information (n=1540, 97.6% of the 
original sample). Twenty-four participants were geocoded to be outside the district of Lilongwe 
and were not considered in this analysis (n = 1516, 96.1%). 
The analysis of the ecological survey data was done using only participants who completed a 
month 6 survey. Three hundred twenty-seven out of the remaining 1516 did not meet this 
criterion, thus a population of 1189 (75.3%) was used for the ecological analysis. Characteristics 
of the excluded populations can be viewed in Table 1. There are significantly more children and 







Table 1 – Excluded Population and Included Population 




Age   
Infant 139 (39.6) 575 (48.4) 
Child 212 (60.4) 614 (51.6) 
Gender   
Male 156 (44.4) 597 (50.2) 
Female 194 (55.3) 590 (49.6) 
Missing 1 (0.3) 2 (0.2) 
Treatment Group   
C3C 130 (37.0) 389 (32.7) 
R3C 117 (33.3) 401 (33.7) 
R3R 102 (29.0) 399 (33.6) 
Missing 2 (0.6) 0 (0) 
Malaria Count (µ, σ) 1.14, 2.12 1.05, 1.86 
 
Summary Statistics 
A description of the final 1189 participants is displayed in Table 2. Note that distance to nearest 
waterway and population density are numeric variables and the values displayed are means 
rounded to the nearest hundredth. The other variables are categorical and the values displayed 
are counts and column percentages.  
 









Age     
Infant 193 (49.6) 188 (46.9) 194 (48.6) 575 (48.4) 
Child 196 (50.4) 213 (53.1) 205 (51.4) 614 (51.6) 
Gender     
Male 193 (49.6) 196 (48.9) 201 (49.9) 597 (50.2) 
Female 195 (50.1) 205 (51.1) 201 (49.9) 590 (49.6) 
Missing 1 (0.3) 0 (0) 1 (0.3) 2 (0.2) 
Roof Type     
Metal sheet 263 (67.6) 270 (67.3) 280 (70.2) 813 (68.4) 
Grass 126 (32.4) 131 (32.7) 119 (29.8) 376 (31.6) 
Window Type     
Glass 178 (45.8) 183 (45.6) 205 (51.4) 566 (47.6) 
Screen 30 (7.7) 44 (11.0) 28 (7.0) 102 (8.6) 
Open 47 (12.1) 43 (10.7) 40 (10.0) 130 (10.9) 
Plastic/paper/carton 56 (14.4) 65 (16.2) 51 (12.8) 172 (14.5) 
Planks 44 (11.3) 28 (7.0) 24 (6.0) 96 (8.1) 
No window 34 (8.7) 38 (9.5) 51 (12.8) 123 (10.3) 
Distance to Nearest Waterway (km) 0.80 0.80 0.86 0.82 
Population Density (per hectare) 49.69 49.57 45.93 48.39 
 
Household locations for the participants within Lilongwe district are displayed in Figure 1a,b. 
The region in the blue box in Figure 1a corresponds to the region displayed in Figure 1b. From 
Figures 1a and 1b, we can see most observations fall within the city of Lilongwe; therefore, 
maps used for display will be of the area indicated in Figure 1b, although we will use all 
observations in Lilongwe district for modeling. 
 
Figure 1a: Households in Lilongwe District Figure 1b: Households in Lilongwe City 
 
 
Since age has been shown to modify vaccine efficacy [6], it is important to understand how it is 
distributed in this study. Figure 2a,b shows that infants were enrolled later in the study period 
than children, and thus had less follow-up time, on average. Figure 3 shows that age was not 
uniformly distributed over the study area. 
Figure 2a: Vaccine 3 Date by Age Group 
 




Figure 3: Probability of Age = Infant 
 
 
Spatial Location as a Proxy for Transmission Intensity 
The spatial distribution of our outcome, malaria incidence, was estimated assuming that malaria 
counts over the study period followed a negative binomial distribution. Figure 4a shows the 
estimates of malaria episodes per year in Lilongwe city, while Figure 4b shows the standard 
error of those estimates. The association seen between higher standard errors and higher malaria 
estimates is partially due to the nature of the negative binomial distribution and partially due to 
malaria incidence being higher in rural areas, which tend to have a lower density of points 
sampled. The results of models 1 and 2, which also attempt to uncover whether malaria is 







Figure 4a: Malaria Incidence Estimates  
   
 
Figure 4b: Standard Error of Estimates 
 
Table 3: Results of Models 1 and 2 
Model and Inputs Parameter Estimates EDF P Value 
1    
Intercept  -7.21487 - <2e-16 
Spatial term - 25.27 <2e-16 
2    
Intercept -7.18643 - <2e-16 
Spatial term - 25.25 <2e-16 
Age -infant -0.05836 - 0.575 
 
EDF stands for estimated degrees of a freedom. A higher EDF for our spatial term corresponds 
to a more complex modeled surface, suggesting that the spatial term is important to our analysis. 
Conversely, an EDF close to 0 suggests that the outcome varies very little by location. Thus, 
spatial location seems to be important in modeling malaria incidence. 
The EDF value is the trace, or the sum of diagonal, of what is essentially the hat matrix for the 
spatial effect. The trace of a hat matrix is equivalent to its rank, which is the number of linearly 
independent columns of the hat matrix, thus, it can be thought of as the level of complexity 
needed to map the observed values to the fitted models. The higher the EDF, the more complex 
the fitted surface. The surface in Table 3 had an EDF of about 25, so it was fairly complex. 
 
Spatial Location and Vaccine Efficacy 
After finding that incidence varied over space during the 2009-2014 phase III clinical trial of the 
RTS,S vaccine, we investigated whether treatment group influenced this pattern of incidence. 
Figure 5a shows Lilongwe City broken up into 64 equally-sized blocks, with malaria incidence 
calculated for each treatment group and for each block. Figures 5b,c show the corresponding 
follow-up time and population used for the block-specific incidence calculations. Only blocks 








Figure 5a: Malaria Incidence by Treatment Group 
 
Figure 5b: Follow-up by Treatment Group
 
Figure 5c: Population by Treatment Group 
 
This method is not optimal for a variety of reasons, the primary reason being that the scale of 
aggregation chosen is always subjective. This can lead to the ‘ecological fallacy,’ which is the 
assumption that because relationship holds at one spatial scale, it will hold at others as well. 
Instead, we can use a spatial random effect to predict malaria incidence. Figure 6 shows the 
malaria incidence estimates by treatment group in Lilongwe city using this method, controlling 
for age group. 
 
Figure 6: Smooth Malaria Incidence by Treatment Group, Controlling for Age Group 
 
 
We can see here that the patterns of malaria incidence are extremely similar between treatment 
groups. These findings are supported by the results of model 3, shown in Table 4, which 
contains an interaction between spatial location and treatment group. No p-values were recorded 
for the interaction terms because ANOVA coding was used, so the default p-values do not test 
the hypothesis of interest. Thus, we must rely on the EDF values to interpret the importance of 
the interaction terms. The interaction terms between treatment group and the spatial random 







Table 4: Results from Model 3 
Model and Inputs Parameter Estimates EDF P Value 
3    
Intercept -6.93291 - <2e-16 
Spatial term - 21.729 <2e-16 
Age – infant vs child 0.04543 - 0.699570 
R3C vs C3C -0.41274 - 0.000178 
R3R vs C3C -0.63131 - 2.29e-08 
Spatial term | C3C - 1.001 - 
Spatial term | R3C - 1.001 - 
Spatial term | R3R - 2.002 - 
 
Ecological Variables as Proxies for Transmission Intensity 
It is possible that using household characteristics better predict the risk of clinical malaria than 
spatial location within our study site, since they are specific to the individual participant’s 
immediate living environment. First we will describe the spatial distribution of roof type and 
window type. Figure 7a shows the estimations of roof type, generated using 𝐸[𝑟𝑜𝑜𝑓𝑖] = 𝑆𝑖 , 
assuming that roof type follows a binomial distribution. Figure 7b shows the estimations of 
window type, which are generated in the same matter, except window type is assumed to follow 
a multinomial distribution. Note that PPC is an abbreviation for plastic, paper, or carton. 
Distance to nearest river and population density are also used in this analysis. Figure 8a,b shows 
the rivers and streams within the Lilongwe District while Figure 9a,b shows the population for 
each 10,000 meter
2














Figure 7a: Probability of Roof Type = Grass 
 
Figure 7b: Probability of Window Type = 
 
 
Figure 8a: Rivers in Lilongwe District  Figure 8b: Rivers in Lilongwe City 
    
 
Figure 9a: Population in Lilongwe District  Figure 9b: Population  in Lilongwe City 
 
     
 
We also needed to show that our ecological variables were associated with malaria incidence. 
Table 5 displays the results of model 4, and suggests that each of our ecological variables is 
associated with malaria incidence. Additionally, we see that the interaction between the vaccine 
and booster group and age group was significant, which was also reported by the RTS,S Clinical 
Trials Partnership. However, the interaction between the three dose vaccine group and age group 
was not found to be significant using our data, meaning that age modified the effect of the 
treatment in the R3R group but not in the R3C group. 
Table 5: Results from Model 4 
Model and Inputs Parameter Estimates EDF P Value 
4    
Intercept -6.645567 - < 2e-16 
Spatial term - 17.78 2.17e-10 
Age – infant vs child -0.246525 - 0.114801 
R3C vs C3C -0.488320 - 0.000945 
R3R vs C3C -0.888004 - 1.47e-08 
R3C | Age – infant 0.094420 - 0.647576 
R3R | Age – infant 0.447045 - 0.038234 
Roof type – grass vs metal 0.457757 - 1.05e-05 
Window type – screen vs glass 0.259368 - 0.116373 
Window type – open vs glass 0.304165 - 0.039550 
Window type-  plastic/paper/carton vs glass  0.364639 - 0.005849 
Window type – planks vs glass 0.044985 - 0.791485 
Window type – none vs glass 0.562385 - 0.000118 
Distance to water -0.226521 - 0.006292 
Population  density -0.006664 - 2.00e-07 
 
Having a grass roof instead of a metal roof was associated with higher malaria incidence. Having 
a missing, an open, or a plastic/paper/carton window instead of a glass window was also 
associated with higher malaria incidence. Living closer to a river or stream and in less densely 
populated areas was associated with higher malaria incidence. We were partially able to replicate 
the results from the main analysis of the phase III trial, finding a significant interaction between 
the vaccine/booster group and age group, but not between the three dose vaccine group and age 
group. This could be due to the fact that we used a smaller sample size for our analysis. 
 
Ecological Interactions with Vaccine Efficacy 
Next we examined whether vaccine efficacy varied base on any of our ecological variables. 
Table 6 shows the group-added last test for each interaction term between treatment group and 
each ecological variable, while Table 7 shows the results from models 5 through 8. 
 
Table 6: Group Added Last Tests for Interaction Terms 
Treatment Group:  P Value 
Roof type 0.571019 
Window type 0.986428 
Distance to water 0.369 
Population Density 0.811124 
 
 
Table 7: Results from Models 5-8 
Model and Inputs Parameter Estimates EDF P Value 
5    
Intercept -7.23834 - < 2e-16 
Age – infant vs child 0.34486 - 0.000387 
R3C vs C3C -0.46871 - 0.001546 
R3R vs C3C -0.58627 - 8.34e-05 
Roof type – grass vs metal 0.85294 - 1.22e-07 
R3C |Roof type – grass 0.24118 - 0.297221 
R3R |Roof type - grass  0.07527 - 0.751946 
6    
Intercept -7.32305 - < 2e-16 
Age – infant vs child 0.52573 - 1.03e-07 
R3C vs C3C -0.43068 - 0.01827 
R3R vs C3C -0.74966 - 5.12e-05 
Window type – screen vs glass 0.41330 - 0.17275 
Window type – open vs glass 0.38642 - 0.12731 
Window type-  plastic/paper/carton vs glass  0.68505 - 0.00322 
Window type – planks vs glass 0.39345 - 0.13597 
Window type – none vs glass 0.89304 - 0.00107 
R3C | Window type – screen -0.21127 - 0.62063 
R3R | Window type – screen 0.22234 - 0.63116 
R3C | Window type – open -0.04638 - 0.90470 
R3R | Window type – open 0.19643 - 0.61901 
R3C | Window type-  ppc 0.26054 - 0.42589 
R3R | Window type-  ppc 0.20325 - 0.56386 
R3C | Window type – planks 0.23130 - 0.58048 
R3R | Window type – planks 0.22903 - 0.62026 
R3C | Window type – none 0.19760 - 0.61004 
R3R | Window type – none 0.33347 - 0.36862 
7    
Intercept -7.11961 - < 2e-16 
Age – infant vs child 0.63700 - 1.48e-10 
R3C vs C3C -0.22729 - 0.1961 
R3R vs C3C -0.37136 - 0.0476 
Distance to water 0.10534 - 0.3161 
R3C |Distance to water -0.11514 - 0.4715 
R3R |Distance to water -0.24446 - 0.1612 
8    
Intercept -6.421410 - < 2e-16 
Age – infant vs child 0.350284 - 0.000264 
R3C vs C3C -0.339444 - 0.034417 
R3R vs C3C -0.673350 - 4.40e-05 
Population  density -0.012170 - 1.81e-09 
R3C | Population  density -0.000164 - 0.956412 
R3R | Population  density 0.001764 - 0.575152 
 




Based on the data from the phase III trial, RTS,S was not equally effective in every trial site. One 
possible explanation for this result was that variable transmission rates created variability in the 
effect of the treatment. Lilongwe, Malawi is a peri-urban city, meaning that transmission 
intensity is likely variable throughout the site. Additionally, neighborhoods differ by quality of 
infrastructure, population density, and nearness to mosquito breeding grounds. Using household 
locations and characteristics as proxies for point-specific transmission intensity, we were able to 
conduct a fairly in-depth examination of whether the vaccine’s efficacy varied based on these 
attributes. 
First, we mapped malaria incidence, finding that it was indeed spatially distributed. This result 
was expected based on our previous knowledge of the study area. Next, we attempted to uncover 
whether vaccine efficacy was spatially distributed. Although our analysis was not based on a 
formal hypothesis test, due to the complexity of the modeling strategy for our spatial effect (i.e., 
thin plate regression splines), the estimated degrees of freedom (EDF) for the interaction terms 
between spatial location and treatment group helped provide insight. When EDF is low, we 
suspect that the term in question does not contribute much to the model. Our interaction terms 
had very low EDF’s, leading us to conclude that spatial location within Lilongwe, Malawi did 
not influence the efficacy of RTS,S during the phase III trial. Examining the spatial pattern of 
malaria incidence, split by treatment group, confirmed this assessment. 
After finding that our ecological variables were related to malaria incidence and distributed non-
uniformly over space, we examined whether the efficacy of RTS,S varied based on roof type, 
window type, distance to nearest river or stream, or population density. We found no evidence 
that the efficacy of the vaccine varied based on any of these variables individually within the 
Lilongwe site. 
Strengths and Limitations 
The major strength of our study was access to household point locations and characteristics. 
Using point locations allowed us to avoid introducing potential biases due to subjective 
aggregation decisions. Another strength of our study was the variation in ecological variables 
and transmission intensity within our study area. 
Our study had a few limitations as well. Primarily, we excluded approximately 25% of our 
observations because of our decision to include only baseline ecological surveys. A more 
thorough analysis would have included every available ecological survey, but we relied on the 
assumption that window type, roof type, distance to water, and population density were time-
invariant over follow up. 
 
Related Studies and Future Research 
One study using the same phase III data in this study, along with precipitation data, found that 
there was no association between rainfall and the efficacy of RTS,S in Lilongwe, Malawi [9]. 
With the added knowledge provided by this study, we can be more confident in claiming that 
transmission intensity does not affect the efficacy of RTS,S, at least in Lilongwe. This analysis 
must be replicated in other sites to generalize this result. 
There are other theories as to why the efficacy of RTS,S varied between sites in the 2009-2014 
phase III trial. One theory is that the vaccine elicits a stronger response from the host immune 
system if the host has a certain human leukocyte antigen (HLA) genotype. The HLA complex 
encodes the proteins present on white blood cells which bind to and present foreign molecules to 
trigger the body’s adaptive immune system. One study found that in 222 RTS,S-vaccinated 
subjects, with 40 different HLA genotypes, HLA genotype did influence immunogenicity and 
efficacy of the RTS,S vaccine [10]. An important follow up will be to survey the HLA types of 
those living in previous trial sites, in order to see if the results match what we would expect. 
Another theory is that the vaccine elicits stronger protection against certain strains of malaria 
than it does against others. One study of 4577 RTS,S -vaccinated participants and 2335 control-
vaccinated participants, who were 5 to 17 months of age and followed for one year, found that 
differences within the circumsporozoite (CSP) protein, the protein targeted by RTS,S, had a 
significant effect on vaccine efficacy [11]. 
Policy Recommendation 
After the phase III trials, there was some discussion that RTS,S should only be offered in high 
transmission intensity areas because the efficacy appeared to be higher under those conditions. 
However, our analysis showed that the vaccine performed uniformly across the city of Lilongwe, 
despite spatial differences in incidence and despite varying household characteristics. If this 
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